McKesson (MCK)
NYSE Market Closed
McKesson Corporation is a major healthcare services and distribution company that plays a central role in the pharmaceutical supply chain. Its core business is sourcing, warehousing, and distributing prescription medicines, including branded drugs, generics, and specialty therapies, to pharmacies, hospitals, health systems, physician offices, and other care providers. In the United States, McKesson is one of the three large drug wholesalers that together handle the vast majority of pharmaceutical distribution, making the company an important infrastructure provider for the healthcare market.
The company’s scale allows it to manage high-volume, low-margin distribution efficiently while helping manufacturers reach healthcare customers and helping pharmacies maintain reliable access to medicines. McKesson serves large retail pharmacy chains, independent pharmacies, mail-order providers, and institutional healthcare customers. It also has operations in Canada, where it participates in pharmaceutical distribution and related healthcare services.
Beyond drug wholesaling, McKesson supplies medical-surgical products, equipment, and practice support to healthcare providers. Its offerings extend into oncology and specialty care services, pharmacy technology, clinical workflow tools, and data-driven solutions that support prescribing, reimbursement, inventory management, and patient access. These adjacent businesses help deepen its relationships across the healthcare system and diversify its sources of revenue.
McKesson’s performance is closely tied to prescription volumes, drug pricing dynamics, manufacturer relationships, and the growth of specialty medicines. The company also operates in a highly regulated environment, with ongoing exposure to compliance requirements, reimbursement pressure, and public scrutiny of pharmaceutical distribution. Its competitive position rests on logistics scale, customer relationships, technology capabilities, and reliability in moving essential medicines through a complex healthcare supply chain.
Last updated
- Market Cap
- 88.56B
- P/E
- 18.6
- P/FCF
- 15.49
- P/S
- 0.22
- Enterprise Value
- 91.11B
- Sector
- Health Care
- Industry
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Address
- 6555 STATE HIGHWAY 161, IRVING, TX, 75039
$663.3 Bn Revenue Cycle Management Market Trends and Global Forecasts Report 2026-2035
Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032
Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032
Evolve Founder Shayla King Opens Enrollment for The Performance + Happiness Lab to Help Senior Leaders Pursue Pay and Promotion
Cardiology EHR: The Digital Pulse Behind a USD 5.44 Billion Cardiac Care Evolution by 2035
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies
Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035
Iterum Therapeutics Provides Business Update
Healthcare Supply Chain Management Market Grows at 11.05% CAGR by 2034
AI in Medical Billing Market Size to Surpass USD 22.46 Billion by 2032, Owing to the Rising Demand for Automation, Accuracy, and Regulatory Compliance in Healthcare | Research by SNS Insider
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
These 5 Dividend Growers Are Outperforming the Market in Total Return
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel
Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025
Cardiovascular Information System Market to Reach USD 2.8 Billion by 2032, Driven by Digital Health Advancements and Growing Cardiac Care Needs – SNS Insider
U.S. Revenue Cycle Management (Integrated, Standalone) Market Trends Analysis Report 2025-2030 | Digital Transformation, Strategic Collaborations, and Regulatory Shifts Drive Growth
3 Dividend Stocks Built for Stability as Growth Trades Cool Off
Radiology Information System Market Forecast Report and Company Analysis 2025-2033 Featuring Koninklijke Philips, Siemens Healthcare, Oracle, McKesson, GE, Fujifilm, Shimadzu, Hologic, Sectra
Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 88.56B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 91.11B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 18.6
- P/B
P/B ratio compares a company's share price to its book value per share.
- -40.78
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.22
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 12.68
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.23
- EPS
- 39.62
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.43%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 15.49
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 14.39
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 5.72B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -219.24%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 5.78%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -3
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.85
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.49
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.06
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 1.31M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 736.78
Income Statement
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Revenue | 96.3B | 106.16B | 103.15B | 97.83B | 90.82B |
| Gross profit | 4.04B | 3.69B | 3.54B | 3.28B | 3.64B |
| Operating income | 2.15B | 1.62B | 1.41B | 1.04B | 1.59B |
| EBITDA | 2.44B | 1.84B | 1.66B | 1.24B | 1.82B |
| Net income | 1.68B | 1.19B | 1.11B | 784M | 1.26B |
| Basic EPS | 13.82 | 9.59 | 8.95 | 6.28 | 10.06 |
| Diluted EPS | 13.55 | 9.63 | 8.92 | 6.25 | 9.84 |
Balance Sheet
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Total assets | 82.32B | 84.19B | 84.16B | 81.31B | 75.14B |
| Total liabilities | 83.16B | 84.29B | 84.74B | 82.17B | 76.83B |
| Total equity | -1.78B | -901M | -1.36B | -1.59B | -1.69B |
| Cash & equivalents | 3.98B | 2.96B | 4B | 2.42B | 5.69B |
| Current assets | 57.21B | 59.7B | 59.89B | 56.8B | 55.4B |
| Current liabilities | 67.02B | 68.13B | 68.03B | 64.33B | 61.6B |
Cash Flow
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | 3.42B | 1.23B | 2.42B | -918M | 7.75B |
| Investing cash flow | 425M | -269M | -24M | -3.56B | -224M |
| Financing cash flow | -2.82B | -2.03B | -961M | 1.18B | -2.86B |
| Change in cash | 1.02B | -1.06B | 1.43B | -3.27B | 4.67B |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 3 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 144 — MCKESSON CORP | View Filing | |
| edgar index | 144 — MCKESSON CORP | View Filing | |
| edgar index | SD — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 144 — MCKESSON CORP | View Filing | |
| edgar index | 144 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| edgar index | 4 — MCKESSON CORP | View Filing | |
| form 4 | Form 4 — TYLER BRIAN S. | View Filing | |
| form 4 | Form 4 — TYLER BRIAN S. | View Filing | |
| form 4 | Form 4 — TYLER BRIAN S. | View Filing | |
| form 4 | Form 4 — TYLER BRIAN S. | View Filing | |
| form 4 | Form 4 — Vitalone Britt J. | View Filing | |
| form 4 | Form 4 — Vitalone Britt J. | View Filing | |
| form 4 | Form 4 — Vitalone Britt J. | View Filing | |
| form 4 | Form 4 — Vitalone Britt J. | View Filing | |
| form 4 | Form 4 — Smith LeAnn B | View Filing | |
| form 4 | Form 4 — Smith LeAnn B | View Filing | |
| form 4 | Form 4 — Smith LeAnn B | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Fraga Francisco | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Rutledge Napoleon B JR | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Lau Michele | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Rodgers Thomas L | View Filing | |
| form 4 | Form 4 — Smith LeAnn B | View Filing |